Biocomposites Release: Independent Study Confirms Superior Properties of ZPC(TM) Enhanced Calcium Composite Bone Grafts
KEELE, England, July 27 /PRNewswire/ -- A recent independent study has confirmed Fortoss Vital®, developed by the Pioneering Orthobiologics Company, Biocomposites, ( http://www.biocomposites.com), as an effective bone replacement material demonstrating superior bone regenerative properties due to its unique negative zeta potential control (ZPC(TM)).